share_log

Aridis Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(8.3%),Lind Global Partners II LLC(8.3%), etc.

Aridis Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Lind Global Fund II LP(8.3%),Lind Global Partners II LLC(8.3%)等

美股SEC公告 ·  2023/03/20 16:35
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息